September 15, 2022ESMO Open117 citationsOpen Access

Hyperthermic intraperitoneal chemotherapy (HIPEC) for the management of primary advanced and recurrent ovarian cancer: a systematic review and meta-analysis of randomized trials

PFPanagiotis FilisKarolinska Institutet DMDavide MauriUniversity Hospital of Ioannina GMGeorgios MarkozannesUniversity of Ioannina

Key Points

Key points are not available for this paper at this time.

Abstract

In primary ovarian cancer the combination of HIPEC with interval CRS and neoadjuvant chemotherapy is a safe option that significantly improved 5-year OS and DFS. Its use in other settings should continue to be considered investigational.

Perguntar à IA

Bookmark

View Full Paper

Cite This Study

Filis et al. (Thu,) studied this question.

synapsesocial.com/papers/69dc99d789c4deb67d359360 https://doi.org/https://doi.org/10.1016/j.esmoop.2022.100586

Perguntar à IA

Bookmark

View Full Paper